I think those advancements could be evidence for both, depending on the details of how the nootropics work, etc. But it still seems worth distinguishing the two things conceptually. My objection in both cases is that only a small part of the evidence for the first comes from the causal impact of the second: i.e. if Codex gave crazy huge productivity improvements, I would consider that evidence for full code automation coming soon, but that’s mostly because it suggests that Codex can likely be improved to the point of FCA, not because it will make OpenAI’s progammers more productive.
I think those advancements could be evidence for both, depending on the details of how the nootropics work, etc. But it still seems worth distinguishing the two things conceptually. My objection in both cases is that only a small part of the evidence for the first comes from the causal impact of the second: i.e. if Codex gave crazy huge productivity improvements, I would consider that evidence for full code automation coming soon, but that’s mostly because it suggests that Codex can likely be improved to the point of FCA, not because it will make OpenAI’s progammers more productive.